Vesencumab
Based on 1 Customer Validation
Vesencumab (MNRP-1685A) is IG1 antibody against neuropilin-1 (NRP-1). Vesencumab binds to NRP-1 and prevents the subsequent coupling of NRP-1 to VEGFR-2. Vesencumab has anti-angiogenic and anti-neoplastic activities. Vesencumab can be used in the research of metastatic solid tumors, including ovarian cancer.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度 : 99.34%
- CAS 番号: 1205533-60-3
- 分子量:145.262 kDa
-
保管条件:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
EGFR アイソフォーム固有の製品をすべて表示
More
生物活性
製品説明
Isotype
Human IgG1 kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
NRP1/VEGF165R/CD34
体外実験
Vesencumab (50 μg/mL, 6 days) inhibits the MAPK signaling pathway by inhibiting the activation of EGFR and PDGFRα, thereby inhibiting the spheroid formation of tumor cells of SUM159 and Hs578T[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:SUM159, MDA-MB-231 and Hs578T
-
Concentration:50 μg/mL
-
Incubation Time:60 min
-
Result:Inhibited pEGFR.
体内実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Mouse SUM159 orthotopic xenograft models[3]
-
Dosage:10 mg/kg
-
Administration:ip, twice a week for 7 weeks
-
Result:Inhibited tumor volume and weight.
臨床実験
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
遺伝子ID
アクセッション番号
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Human IgG1 kappa
アプリケーション
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized Neuropilin-1 Protein, Human (His) can bind Vesencumab. The EC50 for this effect is 5.571 ng/mL. -
Loaded Vesencumab on AHC2 biosensor, can bind Glycoprotein/G Protein, HRSV (95% Homology, HEK293, His, HY-P75814) with an affinity constant of 1.372E-09 M as determined in BLI assay. -
Flow Cytometry analysis of Hela cells labelling NRP1/VEGF165R/CD34 (red) with Vesencumab (anti-NRP1/VEGF165R/CD34) (HY-P99386). Goat Anti-Human IgG (Alexa Fluor 488) (HY-P83776) at a dilution of 1/1000 was used as the secondary antibody. Blue-Human IgG1 kappa (HY-P99001). Black-Unlabelled control, cells without incubation with primary antibody.
化学情報
-
CAS 番号 1205533-60-3
-
性状 Liquid
-
分子量 145.262 kDa
-
Color Colorless to light yellow
-
SMILES
[Vesencumab]
-
別名
MNRP-1685A
-
輸送条件
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
-
データシート (262 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)